Ghost Tree Capital, LLC Roivant Sciences Ltd. Transaction History
Ghost Tree Capital, LLC
- $267 Million
- Q3 2024
A detailed history of Ghost Tree Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 800,000 shares of ROIV stock, worth $9.98 Million. This represents 3.46% of its overall portfolio holdings.
Number of Shares
800,000
Previous 1,000,000
20.0%
Holding current value
$9.98 Million
Previous $10.6 Million
12.66%
% of portfolio
3.46%
Previous 4.31%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$823 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$821 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$675 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$520 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$441 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.79B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...